Downstream Effects of Pandemic-Related Disruptions in Healthcare Utilization and Cost: Insights from Healthcare Claims and Survey Data
Author(s)
Moderator: Luke Boulanger, MA, MBA, IBM Watson Health, Cambridge, MA, USA
Speakers: Brenna Brady, PhD, IBM Watson Health, Laurel, MD, USA; Brandi Hodor, BS, IBM Watson Health, Alexandria, KY, USA; G. Caleb Alexander, MD, MS, Johns Hopkins Bloomberg School of Public Health, Center for Drug Safety and Effectiveness, Baltimore, MD, USA
Presentation Documents
Join experts from Watson Health and Johns Hopkins Bloomberg School of Public Health for a discussion on the implications of the pandemic, and considerations for your outcomes research practice. Backed by in-depth insights from closed-system claims data, supplemented with healthcare consumption survey data, researchers will discuss:
- How delay of diagnosis or alterations in disease management due to the initial pandemic lockdown could have long-term health and economic implications
- The potential impacts of variations such as payer or plan type, specific comorbidity burdens, socioeconomic status, and region of residence on patient outcomes and costs
- Important factors that will need to be addressed to ensure post-pandemic health equity
Conference/Value in Health Info
Code
230